Please login to the form below
oncology
This page shows the latest oncology news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
David Long, head of oncology at MSD UK, added: “This approval from the MHRA marks important progress in advancing a new treatment option to address the significant unmet need of patients
Latest news
-
Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
Chris Boshoff, chief development officer, oncology and rare disease, Pfizer Global Product Development, said: “As the only novel hormone therapy approved for three disease states of prostate cancer in the US,
-
Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
The announcement comes just days after Pfizer agreed to acquire oncology-focused biotech Seagen for a total enterprise value of $43bn, a deal fuelled by sales of the company’s
-
Pfizer to acquire Seagen for $43bn in biggest pharma transaction since 2019
Pfizer has announced that it will acquire Seagen for a total enterprise value of $43bn, which will be a significant boost to the US pharma’s oncology pipeline. ... Oncology continues to be the largest growth driver in global medicine, and this
-
AstraZeneca announces major expansion of Canadian research footprint
placed. The Mississauga-based R&D hub has doubled in size since 2019, AZ said, and is currently leading more than 120 oncology and biopharmaceutical global clinical studies.
-
BioNTech and Weizmann Institute to collaborate at company’s new mRNA centre in Israel
production measures for the commercial manufacturing of personalised oncology therapeutics.”.
More from news
Approximately 533 fully matching, plus 1,685 partially matching documents found.
Latest Intelligence
-
Changing an organisation’s microfoundations – why capabilities count
And a large oncology-focused company exists in a different healthcare habitat from either.
-
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients. ... And there’s plenty more of it in a golden era for oncology innovation.
-
ASH 2022: bad blood but big advances
But these examples only scratch the surface of a burgeoning array of innovation in both haematologic oncology and non-malignant disorders.
-
Design considerations and best practices in clinical research
The increased focus on precision medicine in oncology and rare diseases has led to a marked increase of single-arm trials. ... The increased focus on precision medicine in oncology and rare diseases has led to a marked increase of single-arm trials (SATs)
-
Assessing the impact of rarity on French HTA and pricing decisions
We analysed 22 non-oncology orphan drugs (ODs) that received EMA approval between July 2012 to the end of 2019, focusing on chronic, non-curative treatments.
More from intelligence
Approximately 20 fully matching, plus 238 partially matching documents found.
Latest appointments
-
Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
In his most recent role as senior vice president of customer strategy at BioNTech SE, Arnhofer oversaw commercial activities within the company’s immunology, oncology and product and services units.
-
Havas Health & You appoints Laura Mizrahi as chief creative officer of H4B Chelsea
Her background spans a variety of categories, including women's health, rare disease, oncology, diabetes and immunology.
-
AZ appoints Susan Galbraith as executive vice president, oncology R&D
AstraZeneca (AZ) has announced the appointment of Susan Galbraith (pictured above) as executive vice president, oncology research and development (R&D). ... In her new role, she will lead oncology R&D at AZ from the initial discovery through to
-
CureVac taps Klaus Edvardsen for chief development officer role
Prior to that, he served as senior vice president and head of global medicines development oncology at AstraZeneca. ... In this role, Edvardsen was responsible for the overall development strategy for both oncology and haematology.
-
ICR appoints Kristian Helin as its new chief executive
He was also a unit and division director at the European Institute of Oncology in Milan.
More from appointments
Approximately 12 fully matching, plus 286 partially matching documents found.
Latest from PMHub
-
Mednet Group’s growth spurt
Rachael is a great new edition to the Mednet Group, the new Account Executive carries an undergraduate degree in Biomedical Science and a research Masters in Translational Oncology.
-
5 ways we’re enhancing our services to support our clients in 2023
Jon Koch:We’re continuing to expand partnerships with leading networks of global clinicians in dermatology, hepatology, oncology, and hematology to deliver actionable insights that meet the needs of our clients
-
Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
Kate Shaw, Innovative Trials' Founder &CEM, reflects on the exciting news for patients affected by cancer in the UK. Kate Shaw, Founder &CEO of Innovative trials, welcomes the news that 29 UK experimental cancer medicine centers (ECMCs) are set to
-
The dissemination and consumption of medical literature is evolving
As a pilot, we initially did this for just Cardiology, Neurology, Endocrinology and Oncology. ... The WebMD Health Network includes WebMD Health, Medscape, Jobson Healthcare Information, prIME Oncology, MediQuality, Frontline, Vitals Consumer Services,
-
Can Artificial Intelligence Solve the Healthcare Crisis?
Within oncology, A.I is being used to provide patients with a bespoke treatment plan of all suitable options available.
More from PMHub
Approximately 68 fully matching, plus 136 partially matching documents found.
Subscribe to our email news alerts
-
Technical Sales Representative
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
